Question

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

7 comments7

Total Forecasters426

Community Prediction1%

Make a Prediction

community: 1%

median 1.0%mean 1.5%

Authors:

christian

Opened:

Closes:

Scheduled resolution:

ACX 2024 Prediction Contest

Food and Drug Administration

Medicine

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

81%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Comments

? comments

Authors:

christian

Opened:

Closes:

Scheduled resolution:

ACX 2024 Prediction Contest

Food and Drug Administration

Medicine

We Don't Want Ozempic, Say Surveyed Americans

Newsweek•Oct 9, 2024

Buyer beware: Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers

The Conversation•Oct 9, 2024

Weight-loss drugs lower impulse to eat – and perhaps to exercise too

New Scientist•Oct 10, 2024

Learn more about Metaculus NewsMatch

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

81%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%